ADH4
All-trans-retinol dehydrogenase [NAD(+)] ADH4
Also known as: ADH-2, ADH4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08319
- Gene
- ADH4
- Ensembl
- ENSG00000198099
- Chromosome
- 4
- Canonical length
- 380 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes class II alcohol dehydrogenase 4 pi subunit, which is a member of the alcohol dehydrogenase family. Members of this enzyme family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. Class II alcohol dehydrogenase is a homodimer composed of 2 pi subunits. It exhibits a high activity for oxidation of long-chain aliphatic alcohols and aromatic alcohols and is less sensitive to pyrazole. This gene is localized to chromosome 4 in the cluster of alcohol dehydrogenase genes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
380 residues, UniProt reviewed canonical sequence.
>P08319|ADH4
1 MGTKGKVIKC KAAIAWEAGK PLCIEEVEVA PPKAHEVRIQ IIATSLCHTD ATVIDSKFEG
61 LAFPVIVGHE AAGIVESIGP GVTNVKPGDK VIPLYAPLCR KCKFCLSPLT NLCGKISNLK
121 SPASDQQLME DKTSRFTCKG KPVYHFFGTS TFSQYTVVSD INLAKIDDDA NLERVCLLGC
181 GFSTGYGAAI NNAKVTPGST CAVFGLGGVG LSAVMGCKAA GASRIIGIDI NSEKFVKAKA
241 LGATDCLNPR DLHKPIQEVI IELTKGGVDF ALDCAGGSET MKAALDCTTA GWGSCTFIGV
301 AAGSKGLTIF PEELIIGRTI NGTFFGGWKS VDSIPKLVTD YKNKKFNLDA LVTHTLPFDK
361 ISEAFDLMNQ GKSVRTILIFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADH4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 4,816 nTPM
Expression across tissuesHPA
Tissue
- liver: 4,816 nTPM
- duodenum: 154 nTPM
- small intestine: 22 nTPM
- breast: 4 nTPM
- vagina: 3.1 nTPM
- salivary gland: 2.4 nTPM
Single-cell type
- hepatocytes: 1,345 nCPM
- epicardial cells: 61 nCPM
- adipocytes: 38 nCPM
- fibro-adipogenic progenitors: 32 nCPM
- epididymal clear cells: 31 nCPM
- early spermatids: 29 nCPM
Immune cell
- basophil: 0.4 nTPM
- naive CD8 T-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 11 nTPM
- hypothalamus: 11 nTPM
- cerebral cortex: 11 nTPM
- basal ganglia: 9.7 nTPM
- white matter: 9.3 nTPM
- amygdala: 9.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alcohol metabolic process
- aldehyde metabolic process
- ethanol metabolic process
- fatty acid omega-oxidation
- formaldehyde catabolic process
- retinoid metabolic process
- retinol metabolic process
- alcohol catabolic process
- quinone metabolic process
Molecular functions
- alcohol dehydrogenase (NAD+) activity
- aldose reductase (NADPH) activity
- all-trans retinal binding
- all-trans-retinol dehydrogenase (NAD+) activity
- benzaldehyde dehydrogenase (NAD+) activity
- NAD binding
- quinone reductase (NADPH) activity
- retinol binding
- S-(hydroxymethyl)glutathione dehydrogenase [NAD(P)+] activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADH4 as an antibody target. Whether an autoantibody or antibody against ADH4 could matter depends on whether native ADH4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADH4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ADH4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...